Vincent Frochot
Overview
Explore the profile of Vincent Frochot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Letavernier E, Schwoehrer M, Livrozet M, Saint-Jacques C, Raymond L, Saraeva R, et al.
Kidney Int Rep
. 2024 Aug;
9(8):2584.
PMID: 39156159
[This corrects the article DOI: 10.1016/j.ekir.2021.11.035.].
2.
Vidal H, Salgado V, Alves P, Fonseca N, Frochot V, Ferreira A
Clin Kidney J
. 2024 Aug;
17(8):sfae210.
PMID: 39119522
Classical potassium binders are used in the treatment of hyperkalemia and are widely associated with gastrointestinal side effects, with crystal colonic injury being rare but potentially fatal. In this report,...
3.
Halimi C, Bor C, Chieze R, Saint-Jacques C, Perie S, Wagner I, et al.
J Clin Endocrinol Metab
. 2024 Mar;
109(10):2553-2560.
PMID: 38497124
Context: Primary hyperparathyroidism (PHPT) is commonly diagnosed in the setting of hypercalcemia, whereas normocalcemic primary hyperparathyroidism (NHPT) may be misdiagnosed. Objective: Our objective was to compare patients with hypercalcemic hyperparathyroidism...
4.
Azencot R, Saint-Jacques C, Haymann J, Frochot V, Daudon M, Letavernier E
Sci Rep
. 2024 Mar;
14(1):6078.
PMID: 38480876
Cotrimoxazole (Trimethoprim/Sulfamethoxazole-SMX) is frequently used in critically ill and immunocompromised patients. SMX is converted to N-acetyl-sulfamethoxazole (NASM) and excreted by the kidneys. NASM may form crystals in urine, especially in...
5.
de Berny Q, Saint-Jacques C, Santin A, Mattioni S, Steichen O, Chieze R, et al.
Am J Physiol Renal Physiol
. 2023 Dec;
326(2):F278-F284.
PMID: 38059298
The urine concentration impairment responsible for hyposthenuria in sickle cell nephropathy is currently thought to be a consequence of renal medulla lesions, which lead to nephrogenic diabetes insipidus. The objective...
6.
Mousseaux C, Tang E, Tristant M, Luque Y, Frochot V, Mesnard L, et al.
Kidney Int
. 2023 Sep;
104(4):863-864.
PMID: 37739623
No abstract available.
7.
Schmitt F, Tostivint I, Frochot V, Pieroni L, Caspar-Bauguil S, Plawecki M, et al.
Ann Biol Clin (Paris)
. 2023 Jul;
81(3):331-336.
PMID: 37475174
No abstract available.
8.
Saint-Jacques C, Uzan A, Marechal E, Frochot V, Haymann J, Traxer O, et al.
Kidney Int
. 2022 Oct;
102(5):1197-1198.
PMID: 36272748
No abstract available.
9.
Letavernier E, Schwoehrer M, Livrozet M, Saint-Jacques C, Raymond L, Saraeva R, et al.
Kidney Int Rep
. 2022 May;
7(4):916-919.
PMID: 35497799
No abstract available.
10.
Su Y, Hessou E, Colombo E, Belletti G, Moussadik A, Lucas I, et al.
Amino Acids
. 2022 Mar;
54(8):1123-1133.
PMID: 35296914
It is assumed that genetic diseases affecting the metabolism of cysteine and the kidney function lead to two different kinds of pathologies, namely cystinuria and cystinosis whereby generate L-cystine crystals....